2 results
Approved WMOCompleted
Primary: To compare the pharmacokinetics of raltegravir 400 mg twice daily vs. ralte-gravir 800 mg once daily (QD) by intrasubject comparison. Secondary: To determine the efficacy of an antiretroviral regimen consisting of raltegravir 800mg QD,…
Approved WMOPending
The purpose of the study is to evaluate the safety and effectiveness of the LINX device in the treatment of GERD